| Accession | SAMC2275643 |
|---|---|
| Accession in Other Database | GSA-Human: HRS443873 |
| Sample name | BNI423-LOV |
| Title | BNI423 treated with Lovastatin |
| Sample type | Human sample |
| Organism | Homo sapiens |
| Description | Primary glioblastoma cell line treated with Lovastatin |
| Attributes | *This sample record contains additional controlled-access information that is avaiable from GSA-Human by requesting study HRA003009 in the GSA-Human system. |
| Release date | 2024-03-03 |
| BioProject Accession | PRJCA011142 |
| Submitter | Jian Chen (chenjian@cibr.ac.cn) |
| Organization | Chinese Institute for Brain Research |
| Submission date | 2023-06-18 |
| Resource name | Description |
|---|---|
| GSA-Human (1) | - |
| HRA003009 (Controlled Access) | Glioblastoma (GBM) is the most common and currently incurable brain tumor. Despite the widely described heterogeneity of GBM, clinical therapy targeting different subtypes is deficient. Here, to characterize the drug responses of GBM with different subtypes, we generated a collection of patient-derived glioma cell lines (PDGCs), which retained the transcriptomic and genomic heterogeneity of their parental tissues. |